Abstract Recent studies suggest that the therapeutic effects of stem cell transplantation following myocardial infarction (MI) are mediated by paracrine factors. One of the main goals in the treatment of ischemic heart disease is to stimulate vascular repair mechanisms. Here, we sought to explore the therapeutic angiogenic potential of mesenchymal stem cell (MSC) secretions. Human MSC secretions were collected as conditioned medium (MSC-CM) using a clinically compliant protocol. Based on proteomic and pathway analysis of MSC-CM, an in vitro assay of HUVEC spheroids was performed identifying the angiogenic properties of MSC-CM. Subsequently, pigs were subjected to surgical left circumflex coronary artery ligation and randomized to intravenous MSC-CM treatment or non-CM (NCM) treatment for 7 days. Three weeks after MI, myocardial capillary density was higher in pigs treated with MSC-CM (645 ± 114 vs 981 ± 55 capillaries/mm 2 ; P = 0.021), which was accompanied by reduced myocardial infarct size and preserved systolic and diastolic performance. Intravenous MSC-CM treatment after myocardial infarction increases capillary density and preserves cardiac function, probably by increasing myocardial perfusion.
Introduction
Despite significant advances in myocardial revascularization, coronary artery disease and subsequent myocardial infarction (MI) are leading causes of morbidity and mortality worldwide. One of the main goals in the treatment of ischemic heart disease is the development of effective strategies to stimulate vascular repair mechanisms in order to achieve adequate tissue perfusion.
Although the potential of stem cell therapy for MI is still heavily debated as a result of studies that failed to show improved outcome (Moelker et al., 2006; de Silva et al., 2008; Janssens et al., 2006; Lunde et al., 2006; Meyer et al., 2009; Menasche et al., 2008) , there are several preclinical and clinical studies that demonstrated the therapeutic effects of stem cell transplantation (Hashemi et al., 2008; Wolf et al., 2009; Assmus et al., 2006; Schachinger et al., 2006; Strauer et al., 2002; Yousef et al., 2009) . While robust evidence for cardiomyocyte replacement is still limited, more evidence is accumulating for vascular repair mechanisms following stem cell transplantation (van Laake et al., 2009; Losordo & Dimmeler, 2004; Erbs et al., 2007) . Among the stem cells that have been tested for cardiac repair, mesenchymal stem cells (MSCs) derived from adult bone marrow have emerged as a promising stem cell type for treating cardiovascular disease (Pittenger & Martin, 2004) . Recent studies suggest that at least some of the therapeutic effects of MSCs are mediated by paracrine factors secreted by the cells (Caplan & Dennis, 2006; Gnecchi et al., 2005) . These paracrine factors could be exploited to extend the therapeutic possibilities of MSCs for the treatment of a variety of diseases, including MI. Application of MSC secretions rather than MSCs themselves in order to restore tissue perfusion could enable us to avoid some of the limiting factors associated with cell therapy, such as immune incompatibility, tumorigenicity, costs, and waiting time for ex vivo expansion.
We previously described how human MSC lines can be reproducibly generated from human embryonic stem cell (hESC) lines, which constitute an invariable source of consistently uniform batches of MSCs . In addition, we established for the first time the collection of these MSC secretions as conditioned medium (MSC-CM) in a clinically compliant manner, circumventing exposure to virus, mouse cells, or serum (Sze et al., 2007) . Recently, we demonstrated that MSC-CM treatment following ischemia/ reperfusion injury reduces myocardial apoptosis and oxidative stress (Timmers et al., 2007a ). In the current paper, we reveal the angiogenic potential of clinically compatible MSC-CM and demonstrate in a large animal model that it can be used to improve cardiac function following MI.
Results

MSC-CM stimulates angiogenesis in vitro
Ingenuity pathway analysis of the secretory proteome of MSC-CM revealed that within the physiological system development and function group, cardiovascular system development and function has the highest overrepresentation (P b 10 -12 ) with 75 different focus proteins. Within the group of cardiovascular system development and function, development of blood vessels, angiogenesis, proliferation of endothelial cells, neovascularization, and vascularization are the processes with the highest overrepresentation (supplementary data, Table 1 ).
Having identified the potential involvement of MSC-CM in blood vessel formation, we used an in vitro assay of angiogenesis to further investigate this potential. In an angiogenesis assay based on formation of capillary sprouts by HUVEC spheroids, MSC-CM induced significantly more capillary sprouting compared with NCM (Fig. 1A) . The average length of the sprouts did not increase following MSC-CM treatment compared with NCM (Fig. 1B) . The total length of all sprouts, however, significantly increased in spheroids incubated with MSC-CM when compared with NCM (Fig. 1C) .
In addition, a HUVEC/Matrigel angiogenesis assay was performed, which revealed a longer average tube length with CM compared with NCM (1.07 ± 0.046 vs 0.99 ± 0.041 mm; P = 0.003).
MSC-CM treatment after infarction increases capillary density and decreases collagen density
Capillary density was higher in the border areas following MSC-CM treatment compared with NCM treatment (Figs. 2A and B) . In the remote area, capillary density did not differ between MSC-CM treatment and NCM treatment (Fig. 2C ). We were unable to reliably quantify capillary density in the infarct area due to the unorganized structure of the infarct granulation tissue 3 weeks following MI.
Picrosirius staining revealed that collagen density in the border area and in the remote myocardium was lower in pigs treated with MSC-CM compared with pigs treated with NCM. In the infarct area, no difference was detected between the treatment groups (Fig. 3) .
MSC-CM preserves cardiac function following MI
One hour after coronary artery ligation, cardiac function decreased similarly in both groups. Fractional area shortening decreased from 45.8 ± 1.9 to 32.3 ± 2.0% in the NCM group and from 46.9 ± 4.6 to 29.7 ± 3.4% in the MSC-CM group (P = 0.670). Also cardiac output (2.80 ± 0.10 L/min (NCM) vs 2.67 ± 0.22 L/min (MSC-CM); P = 0.596), mean aortic pressure (90 ± 8.3 mm Hg (NCM) vs 84 ± 5.4 mm Hg (MSC-CM); P = 0.544) and dP/dt MAX (1135 ± 83 mm Hg/s (NCM) vs 1096 ± 83 mm Hg/s (MSC-CM); P = 0.741) were similar in both groups 1 h after coronary artery ligation.
In the 3 weeks following MI, the LV internal areas increased in all pigs. However, the increase in LV internal area tended to be more pronounced in NCM-treated animals, pointing to reduced remodeling in MSC-CM-treated pigs (Figs. 4A and B) . Echocardiographic wall thickness of the infarct area decreased in pigs treated with NCM, but not in pigs treated with MSC-CM (Fig. 4C) . The fractional area shortening was higher following MSC-CM treatment, which reflects increased systolic cardiac performance (Fig. 4D) . Also other systolic functional parameters such as ejection fraction, dP/dt MAX , stroke volume, and stroke work were higher in animals treated with MSC-CM. Improved cardiac function translated into improved hemodynamic parameters, with the mean arterial pressure and cardiac output being higher in MSC-CM-treated pigs. In addition, diastolic function improved, as assessed with dP/dt MIN and diastolic chamber stiffness. All functional parameters are summarized in Table 1 . Myocardial infarct size 3 weeks following coronary artery ligation was smaller in MSC-CM-treated pigs compared to NCMtreated pigs (11.6 ± 2.0% vs 16.6 ± 1.2% of the LV; P = 0.050).
Two pigs died during the surgical procedure due to refractory ventricular fibrillation before treatment with MSC-CM or NCM, and were therefore excluded from the study. Two pigs (1 treated with MSC-CM and 1 treated with NCM) died in the third week following MI without signs of heart failure or cardiac rupture, probably due to ventricular tachycardia/fibrillation.
Discussion
Here, we demonstrate that human MSC-CM treatment enhances capillary density, resulting in reduced myocardial infarct size and preserved systolic and diastolic function in a porcine model of myocardial infarction.
Recently, it was demonstrated that administration of MSC secretions improved outcome in a murine model of MI (Gnecchi et al., 2005) . Vascular repair mechanisms constitute an important means to reduce myocardial injury and to improve cardiac function following MI. Although the therapeutic potential of stem cell transplantation is still a subject of discussion, evidence for vascular repair mechanisms following stem cell transplantation is growing (van Laake et al., 2009; Losordo & Dimmeler, 2004; Erbs et al., 2007) . If vascular repair mechanisms are induced by paracrine factors, application of stem cell secretions may extend the repertoire of stem cell-based therapies with a different dimension.
An in vitro sprouting assay confirmed Ingenuity analysis of earlier MSC-CM proteomics data and identified the angiogenic potential of MSC-CM. In order to investigate the therapeutic potential of MSC-CM to stimulate angiogenesis in vivo, we used a porcine model of myocardial infarction. During myocardial ischemia following coronary artery ligation, cardiomyocytes in the central infarct perish within minutes to hours after coronary occlusion. The border zone of the ischemic area, however, contains injured but viable cells under hypoperfused and hypoxic conditions which may either be salvaged or die, depending on the conditions after ischemia. Restoration of myocardial perfusion by means of angiogenesis restores the metabolic needs of cardiomyocytes in the border area and offers the cells a better chance of survival, which in turn could lead to reduced myocardial injury. Intracoronary delivery of bone marrow-derived progenitor cells has been suggested to promote vascular repair following MI, potentially via paracrine mechanisms (Erbs et al., 2007) . Such effect was also observed in a rodent model of hind limb ischemia (Kinnaird et al., 2004) . As became evident from our histological analyses, MSC-CM increased capillary density in the border areas and myocardial infarct size was reduced, which was accompanied by preserved LV dimensions and cardiac function.
Besides stimulation of angiogenesis, it cannot be excluded that also other mechanisms contributed to reduction of myocardial infarct size and preservation of myocardial function. With preserved left ventricular dimensions and infarct thickness, inhibition of post MI cardiac remodeling is a potential contributing mechanism. Collagen density in the border area and remote myocardium was lower in pigs treated with MSC-CM. Cardiac fibrosis is associated with heart failure following myocardial infarction and may contribute to progression of systolic and diastolic dysfunction (Burlew & Weber, 2002; Cleutjens et al., 1999) . We recently demonstrated that intravenous and intracoronary MSC-CM treatment reduces myocardial apoptosis and oxidative stress (Timmers et al., 2007a) . In that study, cardiomyocyte death was targeted acutely following ischemia and reperfusion injury. In the current study, treatment was started late after coronary artery ligation, and a model of permanent coronary artery ligation was used in order to investigate the angiogenic potential of MSC-CM and its effect on cardiac function independent of reduction of reperfusion injury. The fact that cardiac function improved using this protocol shows that there may be additional benefit from prolonged treatment with MSC secretions.
For this study, a permanent coronary artery ligation was performed in anesthetized animals and functional measurements were performed with open chest. In addition, we have not been able to investigate the effect of common comorbidities such as hypertension, dyslipidemia, and diabetes, which might influence the biologic effect of MSC secretions. Due to the permanent coronary artery ligation, we were not able to assess the area at risk 3 weeks post MI. We were not able to oversee the effects of human protein injection on the immune system of the porcine host and the potential influence on study endpoints. Furthermore, the molecular mechanism for the induction of angiogenesis and/ or arteriogenesis and an exact determination of the responsible angiogenic factors are still lacking. Several clinical trials with potent angiogenic factors failed to improve outcome in patients (Henry et al., 2003; Simons et al., 2002) . It is not clear how paracrine factors in stem cell transplants, or the paracrine factors alone, can induce a better effect. Most likely, a combination of angiogenic factors rather than a single protein is responsible. Also exosomes could play an important role. We previously demonstrated exosomes in MSC-CM to contain and deliver cardioprotective compounds preventing cardiomyocyte death following ischemia and reperfusion injury (Lai et al., 2010) . Exosomes constitute a potential delivery tool to Here, we demonstrate that human MSC secretions stimulate angiogenesis. These data support the hypothesis that MSC transplantation induces vascular repair mechanisms via paracrine pathways. Most importantly, human MSC secretions harvested as conditioned medium using a clinically compliant protocol reduced infarct size and preserved cardiac function in a large animal model of myocardial infarction. The study therefore identifies MSC-CM as a novel therapeutic biologic in the improvement of cardiac function after myocardial infarction.
Methods
MSC-CM preparation
The protocols for MSC generation and CM preparation have been described in previous papers Sze et al., 2007) . In short, a chemically defined serum-free culture medium (DMEM without phenol red, supplemented with insulin, transferrin, and selenium, 5 ng/ml FGF2, 5 ng/ml PDGF AB, glutamine-penicillin-streptomycin, and ß-mercaptoethanol) was conditioned by MSCs derived from human embryonic stem cells (hESCs) using a clinically compliant protocol. Three polyclonal, karyotypically stable, and phenotypically MSC-like cultures, that do not express pluripotency-associated markers but displayed MSC-like surface antigens (CD29+, CD44+, CD49a+/e+, CD105+, CD166+, CD34-, CD45-) and gene expression profile, were generated by trypsinization and propagation of hESCs from either the HuES9 hESC line or the H1 hESC line in feeder-and serum-free selection media . One of these cultures, HuES9.E1, can be stably expanded for at least 80 population doublings. To harvest MSC secretions, hESC-derived MSC cultures were transferred to a chemically defined, serum-free culture medium to condition the medium for 3 days before the media containing MSC secretions were collected, clarified by centrifugation, concentrated 25 times using 10-kDa MW cutoff ultrafiltration membranes and sterilized by filtration through a 220-nm filter. The protein concentration after concentration was 0.50 mg/ml. As a negative control, the above-noted serumfree culture medium was processed equally (nonconditioned medium [NCM] ).
Ingenuity pathway analysis
For this analysis we used the proteomic data obtained previously (Sze et al., 2007) . Bioinformatic analysis was performed using Ingenuity pathway analysis (Ingenuity IPA-2002 version 7.1). The 201 proteins were uploaded in Ingenuity with Ingenuity Knowledge Base as a reference set and direct and indirect relationships were included. All molecules or relationships were considered for the filter summary. In the summary, the focus was on Top Bio functions in which physiological system development and function was analyzed in depth.
HUVEC spheroid assay
Spheroids were formed from HUVECs to determine the effect of conditioned medium on angiogenic sprout formation (Korff & Augustin, 1998) . Spheroids were formed overnight in 20% HR, bpm 66 ± 4 73 ± 6 84 ± 6 86 ± 6 28 ± 12 12 ± 11 MAP, mm Hg 95 ± 5 89 ± 5 66 ± 6 85 ± 5 * -30 ± 5 -5 ± 8 * CO, L/min 3.1 ± 0.1 3.0 ± 0.2 3.7 ± 0.6 5.3 ± 0.5 23 ± 21 78 ± 20 dP/dt max, mm Hg/s 1213 ± 77 1241 ± 56 1157 ± 162 1650 ± 124 * 4 ± 13 40 ± 9 * dP/dt min, mm Hg/s -1274 ± 122 -1130 ± 96 -883 ± 98 -1313 ± 95 * 27 ± 9 -19 ± 19 * EDP, mm Hg 8.0 ± 0.3 7.1 ± 0.6 13.3 ± 1.6 12.1 ± 1.1 68 ± 21 94 ± 42 WT infarct, cm 0.79 ± 0.04 0.83 ± 0.05 0.55 ± 0.02 0.79 ± 0.05 * -27 ± 4 -5 ± 4 * Lvia (ED), cm2
15.8 ± 0.5 14.2 ± 1.0 26.0 ± 1.8 21.8 ± 1.5 64 ± 12 55 ± 12 Lvia (ES), cm2
8.5 ± 0.4 7.6 ± 0.9 17.7 ± 1.6 12.5 ± 0.9 * 104 ± 14 60 ± 14 * FAS, % 45.8 ± 1.9 46.9 ± 4.6 32.6 ± 2.2 42.4 ± 3.3 * -28 ± 6 -6 ± 8 * SV, ml 48 ± 3 42 ± 2 43 ± 4 62 ± 3 * -4 ± 11 52 ± 10 * EDV, ml 134 ± 16 129 ± 9 ESV, ml 93 ± 15 73 ± 9 EF, % 33.7 ± 4.4 49.1 ± 3.3 * SW, mm Hg·ml 2497 ± 333 4595 ± 361 * Stiffness, mm Hg/ml 0.26 ± 0.04 0.14 ± 0.02 * Summary of cardiac functional parameters of pigs treated with NCM (n = 9) and MSC-CM (n = 9), determined with echocardiography and conductance catheter-based LV pressure and volume measurements. MI indicates myocardial infarction; HR, heart rate; MAP, mean arterial pressure; CO, cardiac output; EDP, end-diastolic pressure; WT, wall thickness; LVia, left ventricular internal area; SV, stroke volume; EDV, end-diastolic volume; ESV, end-systolic volume; EF, ejection fraction; SW, stroke work; Stiffness, end-diastolic chamber stiffness. * P b 0.05 vs NCM.
methocel in culture medium and subsequently embedded in a collagen-methocel matrix. Sprouting was induced overnight with MSC-CM (n = 12) or non-CM (NCM) (n = 12) to determine the effect of the secreted chemotactic proteins on capillary sprouting. After overnight sprouting, spheroids were fixed in 10% formaldehyde and pictures were taken and the length and number of sprouts were quantified.
Animals
All experiments were performed in accordance with the "Guide for the Care and Use of Laboratory Animals" prepared by the Institute of Laboratory Animal Resources and with prior approval by the Animal Experimentation Committee of the Faculty of Medicine, Utrecht University, the Netherlands.
Sample size calculation
In a previous study, the mean fractional area shortening (FAS), after LCx ligation was 36.5% (Timmers et al., 2007b) .
With an alpha of 0.05, power of 0.80, SD of 5.8, and difference of 20% considered relevant, 10 animals per group were needed. To allow for 10% mortality, 11 animals per group were enrolled.
Pig study design
Myocardial infarction was induced in 22 Dalland Landrace pigs (60-70 kg, IDDLO, Lelystad, the Netherlands) by surgical left circumflex coronary artery (LCx) ligation. Two pigs died perioperatively before randomization and were therefore excluded from the study. The remaining 20 pigs were randomized after surgery by using sealed envelopes to intravenous treatment with MSC-CM (2.0 ml MSC-CM, i.e., 1.0 mg protein) or 2.0 ml NCM, initiated 4 h after coronary artery ligation and the treatment was continued for 7 days twice daily via a catheter inserted into the jugular vein. The pigs were sacrificed 3 weeks after MI. To prevent thrombotic complications and arrhythmias, all pigs were treated with clopidogrel 75 mg/day from 3 days before MI until termination and amiodarone 400 mg/day from 10 days before MI until termination.
Myocardial infarction and operational procedure
Pigs were anesthetized as described previously (Timmers et al., 2007b) . During the entire operation, electrocardiogram, arterial pressure, and capnogram were continuously monitored. After median sternotomy, the left ventricular pressure (LVP) was measured using a pressure tipped Millar catheter that was inserted through the apex into the left ventricle. A transonic flow probe (Transonic Systems Inc., Ithaca, NY, USA) was placed around the proximal aorta to measure cardiac output. Sutures were then tightened to permanently occlude the proximal LCx. Internal defibrillation with 50 J was used when VF occurred. Prior to and 1 h after induction of the infarct, echocardiography was performed. After stabilization of hemodynamic parameters and heart rhythm, the thorax was closed and the animals were allowed to recover. Three weeks after induction of myocardial infarction, the animals were anesthetized once more and the sternum was reopened. Echocardiography and conductance catheter-based pressure-volume (PV) loop recordings were obtained to assess cardiac function and geometry. After the functional measurements the heart was excised for laboratory analysis.
Immunohistochemistry
Three weeks following MI, myocardial biopsies were obtained from the infarct area, border area, and remote area and fixated in 4% formalin for 24 h before being embedded in paraffin. To determine capillary density, a lectin staining, delineating the endothelium, was performed following antigen retrieval by boiling in 10 mM citrate buffer. Endogenous biotin was blocked using 0.1% avidin solution (DakoCytomation Biotin Blocking system X0590) for 15 min at room temperature (RT) and subsequently with 0.01% biotin solution (Dako) for 15 min at RT. After blocking with 3.0% BSA in PBS, the sections were incubated overnight with biotinylated BS-1 (Sigma, L3759) in a 1:300 dilution in PBS with 0.1% BSA and subsequently with streptavidin-HRPO (1:1000 in PBS) for 1 h at RT. Finally, the sections were incubated for 30 min in 3-amino-9-ethylcarbazole (AEC) and stained with hematoxylin before being embedded. Capillary density was expressed as the number of capillaries per square millimeter tissue. Quantification of collagen density was performed using picrosirius red staining with circularly polarized light and digital image microscopy after conversion into grayvalue images, as described before (Timmers et al., 2007b) .
Myocardial infarct size
After excision of the heart, the LV was isolated and cut into 5 slices from apex to base. To discriminate infarct tissue from viable myocardium, the slices were incubated in 1% triphenyltetrazolium chloride (TTC, Sigma-Aldrich Chemicals, Zwijndrecht, Netherlands) in 37°C Sörensen buffer (13.6 g/L KH 2 PO 4 + 17.8 g/L Na 2 H PO 4 ·2H 2 O, pH 7.4) for 15 min. All slices were scanned from both sides and in each slide the infarct area was compared to total area using digital planimetry software. After correction for the weight of the slices, infarct size was calculated as a percentage of the LV.
Cardiac function
Midpapillary short axis epicardial echocardiography was performed before coronary artery ligation, 1 h after and 3 weeks after coronary artery ligation (Prosound SSD-5000, 5 MHz probe UST-5280-5, Aloka Holding Europe AG, Zug, Switzerland). Wall thickness (WT) of the infarct area and left ventricular internal area (LVia) were measured at enddiastole (ED) and end-systole (ES). Systolic wall thickening (SWT) was calculated as (WT(ES) -WT(ED))/WT(ED) * 100 (%) and fractional area shortening (FAS) as (LVia(ED) -LVia(ES))/ LVia(ED) * 100 (%). Left ventricular (LV) pressure-volume loops were measured using a conductance catheter as described previously (Timmers et al., 2009 ). Diastolic chamber stiffness was quantified by means of linear regression of the end-diastolic pressure-volume relationship (Sagawa, 1981) .
Data analysis
The data were collected and analyzed in a blinded fashion. Data are presented as mean ± SE. Mortality was compared using Fisher's exact test. Capillary sprouting was compared using a one-way ANOVA and Bonferroni post hoc tests. A twoway ANOVA with Bonferroni post hoc tests was used to compare capillary density and collagen density in the myocardial tissue. Cardiac functional parameters that were also measured before MI (baseline) were compared using a two-way ANOVA for repeated measures and Bonferroni post hoc tests. For cardiac functional parameters that were measured only 3 weeks after MI, Student's t test was used.
